ERBB2 and gastric cancer: We then examined another HER2-overexpressing intestinal-type gastric cancer cell line, NCI-N87, derived from liver metastasis of a Caucasian patient (Park et al, 1990), and confirmed the high gefitinib sensitivity such as that found in the GLM series.